HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$4.37
Day range
$4.30 - $4.48
Year range
$3.79 - $12.36
Market cap
2.30B USD
Avg Volume
50.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.18M | -80.16% |
Operating expense | 41.63M | 10.25% |
Net income | -162.25M | -69.29% |
Net profit margin | -3.14K | -753.24% |
Earnings per share | -0.36 | -5.88% |
EBITDA | -151.16M | -65.82% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 659.84M | 54.29% |
Total assets | 1.40B | 92.64% |
Total liabilities | 352.58M | 74.60% |
Total equity | 1.05B | — |
Shares outstanding | 521.26M | — |
Price to book | 2.05 | — |
Return on assets | -31.87% | — |
Return on capital | -40.30% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -162.25M | -69.29% |
Cash from operations | -117.36M | -98.16% |
Cash from investing | -2.55M | 44.13% |
Cash from financing | 251.34M | 1,426.79% |
Net change in cash | 133.30M | 384.09% |
Free cash flow | -63.40M | -276.07% |
About
Founded
2013
Headquarters
Website
Employees
800
